Peroxiredoxin 6 in human brain: Molecular forms, cellular distribution and association with Alzheimer's disease pathology

Acta Neuropathologica

Volumn 115, Issue 6, 2008, Pages 611-622

  Power, John H T ^a   Asad, Sana ^a   Chataway, Tim K ^a   Chegini, Fariba ^a   Manavis, James ^b   Temlett, James A ^b   Jensen, Poul H ^c   Blumbergs, Peter C ^b   Gai, Wei Ping ^a  

^a FLINDERS UNIVERSITY   (Australia)

^b INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

^c AARHUS UNIVERSITY   (Denmark)

Author keywords

Alzheimer's disease; Astrocytes; Molecular forms; Oxidative stress; Peroxiredoxin 6

Indexed keywords

AMYLOID BETA PROTEIN; PEROXIREDOXIN; PEROXIREDOXIN 6; REACTIVE OXYGEN METABOLITE; TAU PROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; AMYGDALOID NUCLEUS; ARTICLE; ASTROCYTE; BRAIN TISSUE; CELL INTERACTION; CELLULAR DISTRIBUTION; CINGULATE GYRUS; CONFOCAL MICROSCOPY; CONTROLLED STUDY; FEMALE; FRONTAL CORTEX; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; MALE; NERVE CELL; NEUROPATHOLOGY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; TWO DIMENSIONAL ELECTROPHORESIS; WESTERN BLOTTING;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANALYSIS OF VARIANCE; ASTROCYTES; BRAIN; CELL COUNT; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; HUMANS; MALE; MIDDLE AGED; NEURONS; PEROXIREDOXIN VI; TAU PROTEINS;

EID: 43649097960     PISSN: 00016322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00401-008-0373-3     Document Type: Article

References (36)

1. Akama KT, Van Eldik LJ (2000) β-amyloid stimulation of inducible nitric oxide synthetase in astrocytes is interleukin-1β and tumour necrosis factor-α (TNFα)-dependent, and involves a TNFα receptor-associated factor and NKFκB-inducing kinase-dependent signalling mechanism. J Biol Chem 275:7918-7924
2. Barkats M, Millecamps S, Abrioux P, Geoffroy MC, Mallet J (2000) Overexpression of glutathione peroxidase increases the resistance of neuronal cells to β-mediated neurotoxicity. J Neurochem 75:1438-1446
3. Beal MF (2002) Oxidatively modified proteins in aging and disease. Free Radic Biol Med 32:797-803
4. Burdick D, Soreghan B, Kwon M, Kosmoski J, Knauer M, Henschen A, Yates J, Cotman C, Glabe C (1992) Assembly and aggregation properties of synthetic Alzheimer's A4/β amyloid peptide analogs. J Biol Chem 267:546-554
5. Butterfield DA, Castegna A, Lauderback C M, Drake J (2002) Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer's disease brain contribute to neuronal death. Neurobiol Aging 23:655-664
6. Butterfield DA, Lauderback CM (2002) Lipid peroxidation and protein oxidation in Alzheimer's disease brain: Potential causes and consequences involving amyloid β-peptide-associated free radical oxidative stress. Free Radic Biol Med 32:1050-1060
7. Castegna A, Lauderback CM, Mohmmad-Abdul H, Butterfield DA (2004) Modulation of phospholipid asymmetry in synaptosomal membranes by the lipid peroxidation products, 4-hydroxynonenal and acrolein: Implications for Alzheimer's disease. Brain Res 1004:193-197
8. Chen L, Richardson JS, Calwell JE, Ang LC (1994) Regional brain activity of free radical defence enzymes in autopsy samples from patients with Alzheimer's disease and nondemented controls. Int J Neurosci 75:83-90
9. 2 activities. J Biol Chem 275:28421-28427
10. Chong ZZ, Li F, Maiese K (2005) Stress in the brain: Novel cellular mechanisms of injury linked to Alzheimer's disease. Brain Res Rev 49:1-21
11. Cummings RC, Dargusch R, Fischer WH, Schubert D (2007) Increase in expression levels and resistance to sulfhydryl oxidation of peroxiredoxin isoforms in amyloid β-resistant nerve cells. J Biol Chem 282:30523-30534
12. Dickson TC, Vickers JC (2001) The morphological phenotype of β-amyloid plaques and associated neuritic changes in Alzheimer's disease. Neuroscience 105:99-107
13. Fisher AB, Dodia C, Manevich Y, Chen JW, Feinstein SI (1999) Phospholipid hydroperoxides are substrates for non-selenium glutathione peroxidase. J Biol Chem 274:21326-21334
14. Grundke-Iqbal I, Iqbal K, Tung Y, Quinlan M, Wisniewski HM, Binder L (1986) Abnormal phosphorylation of the microtubule-associated protein τ (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci USA 83:4913-4917
15. Hayn M, Kremser K, Singewald N, Cairns N, Nemethova M, Lubec B, Lubec G (1996) Evidence against the involvement of reactive oxygen species in the pathogenesis of neuronal death in Down's syndrome and Alzheimer's disease. Life Sci 57:537-544
16. Hensley K, Hall N, Subramaniam R, Cole P, Harris M, Aksenov M, Aksenova M, Gabbita SP, Wu JF, Carney JM, Lovell M, Markesbery WR, Butterfield DA (1995) Brain regional correspondence between Alzheimer's disease histopathology and biomarkers of protein oxidation. J Neurochem 65:2146-2156
17. Hu J, Akama KT, Krafft GA, Chromy BA, Van Eldik LJ (1998) Amyloid-β peptide activates cultured astrocytes: Morphological alterations, cytokine induction and nitric oxide release. Brain Res 785:195-206
18. Kato S, Gondo T, Hoshii Y, Takahashi M, Yamada M, Ishihara T (1998) Confocal observation of senile plaques in Alzheimer's disease: Senile plaque morphology and relationship between senile plaques and astrocytes. Pathol Int 48:332-340
19. Kawaguchi-Niida M, Shibata N, Morikawa S, Uchida K, Yamamoto T, Sawada T, Kobayashi M (2006) Crotonaldehyde accumulates in glial cells of Alzheimer's disease brain. Acta Neuropathol 111:422-429
20. Kish SJ, Morito CL, Hornykiewicz O (1986) Brain glutathione peroxidase in neurodegenerative disorders. Neurochem Pathol 4:23-28
21. Khalil Z, Poliviou H, Maynard CJ, Beyreuther K, Masters CL, Li QX (2002) Mechanism of peripheral microvascular dysfunction in transgenic mice overexpressing the Alzheimer's disease amyloid Abeta protein. J Alzheimers Dis 4:467-478
22. Kosik KS, Joachim CL, Selkoe DJ (1986) Microtubule-associated protein tau (τ) is a major component of paired helical filaments in Alzheimer disease. Proc Natl Acad Sci USA 83:4044-4048
23. Lee SL, Hwang YS, Kim YJ, Kwon K, Kim HJ, Kim K, Chae HZ (2001) Cyclophilin A binds to peroxiredoxins and activates its peroxidase activity. J Biol Chem 276:29826-29832
24. Liu Q, Smith MA, Avila J, DeBernardis J, Kansal M, Takeda A, Zhu X, Nunomura A, Honda K, Moreira PI, Oliveira CR, Santos MS, Shimohama S, Aliev G, de la Torre J, Ghanbari HA, Siedlak SL, Harris PLR, Sayre LM, Perry G (2005) Alzheimer-specific epitopes of tau represent lipid peroxidation-induced conformations. Free Radic Biol Med 38:746-754
25. Masters CL, Simms G, Weinman NA, Multhaup G, McDonald BL, Beyreuther K (1985) Amyloid plaque core protein in Alzheimer's disease and Down syndrome. Proc Natl Acad Sci USA 82:4245-4249
26. Migliore L, Fontana I, Trippi F, Colognato R, Coppede F, Tognoni G, Nucciarone B, Siciliano G (2005) Oxidative DNA damage in peripheral leukocytes of mild cognitive impairment and AD patients. Neurobiol Aging 26:567-573
27. Omar RA, Chyan YJ, Andorn AC, Poeggeler B, Robakis NK, Pappolla MA (1999) Increased expression but reduced activity of antioxidant enzymes in Alzheimer's disease. J Alzheimers Dis 1:139-145
28. Pardridge WM, Vinters HV, Yang J, Eisenberg J, Choi TB, Touretellotte WW, Huebner V, Shively JE (1987) Amyloid angiopathy of Alzheimer's disease: Amino acid composition and partial sequence of a 4,200-dalton peptide isolated from cortical microvessels. J Neurochem 49:1394-1401
29. Peshenko IV, Shichi H (2001) Oxidation of active center cysteine of bovine 1-Cys peroxiredoxin to the cysteine sulfenic acid form by peroxide and peroxynitrite. Free Radic Biol Med 31:292-303
30. Power JHT, Shannon JM, Blumbergs PC, Gai W (2002) Nonselenium glutathione peroxidase in human brain: Elevated levels in Parkinson's disease and dementia with Lewy bodies. Am J Pathol 161:885-894
31. Power JHT, Nicholas TE (1999) Immunohistochemical localization and characterization of a rat Clara cell 26-kDa protein (CC26) with similarities to glutathione peroxidase and phospholipase A2. Exp Lung Res 25:379-392
32. Romero FJ, Bosch-Morell F, Romero MJ, Jareno EJ, Romero B, Marin N, Roma J (1998) Lipid peroxidation products and antioxidants in human disease. Environ Health Perspect 106:1229-1234
33. Schonberger SJ, Edgar PF, Kydd R, Faull RLM, Cooper GJS (2001) Proteomic analysis of the brain in Alzheimer's disease: Molecular phenotype of a complex disease process. Proteomics 1:1519-1528
34. Sizova D, Charbaut E, Delalande F, Poirier F, High AA, Parker F, Dorsselaer F, Duchesne M, Diu-Hercend A (2007) Proteomic analysis of brain tissue from an Alzheimer's disease mouse model by two-dimensional difference gel electrophoresis. Neurobiol Aging 28:357-370
35. Smith MA, Nunomura A, Lee H, Zhu X, Moreira PI, Avila J, Perry G (2005) Chronological primacy of oxidative stress in Alzheimer's disease. Neurobiol Aging 26:579-580
36. Wood ZA, Schroder E, Harris JR (2003) Poole LB Structure, mechanism and regulation of peroxiredoxins. Trend Biochem Sci 28:32-40